From: Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
Baseline
Endpoint
P
SOD(u/ml)
90.00 ± 16.62
108.81 ± 27.02
0.009
8-iso-PG (pg/ml)
2.15 ± 0.61
1.641 ± 0.42
0.012